3 Growth Companies With Insider Ownership As High As 37%

In a week marked by volatility and competitive pressures in the AI sector, global markets have been navigating a complex landscape with mixed results across major indices. While U.S. stocks faced challenges from AI competition fears and tariff risks, European markets found some relief from strong earnings and interest rate cuts by the ECB. In this environment, companies with high insider ownership can be appealing as they often demonstrate strong alignment between management and shareholder interests, potentially providing stability amid market fluctuations.

Top 10 Growth Companies With High Insider Ownership

Name	Insider Ownership	Earnings Growth
Lavvi Empreendimentos Imobiliários (BOVESPA:LAVV3)	17.3%	22.8%
SKS Technologies Group (ASX:SKS)	29.7%	24.8%
Propel Holdings (TSX:PRL)	36.5%	38.9%
On Holding (NYSE:ONON)	19.1%	29.7%
Pharma Mar (BME:PHM)	11.9%	44.7%
Kingstone Companies (NasdaqCM:KINS)	20.8%	24.9%
Elliptic Laboratories (OB:ELABS)	26.8%	121.1%
Plenti Group (ASX:PLT)	12.7%	120.1%
Brightstar Resources (ASX:BTR)	16.2%	86%
Findi (ASX:FND)	35.8%	110.7%

Click here to see the full list of 1478 stocks from our Fast Growing Companies With High Insider Ownership screener.

Underneath we present a selection of stocks filtered out by our screen.

Dioo Microcircuits Jiangsu (SHSE:688381)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Dioo Microcircuits Jiangsu focuses on the research, development, design, and manufacture of high-performance analog chips in China and has a market cap of CN¥4.04 billion.

Operations: Unfortunately, the revenue segment details for Dioo Microcircuits Jiangsu are missing from the provided text. Please provide the specific revenue segment information to enable a concise summary.

Insider Ownership: 23.3%

Dioo Microcircuits Jiangsu demonstrates potential as a growth company with high insider ownership, highlighted by its forecasted revenue growth of 25.5% annually, outpacing the Chinese market's 13.3%. Earnings are expected to grow significantly at 69.31% per year, surpassing market averages. However, profit margins have decreased from last year and return on equity is projected to remain low at 4.7%. A recent share buyback program aims to enhance shareholder value and support an employee stock ownership plan.

• Click here and access our complete growth analysis report to understand the dynamics of Dioo Microcircuits Jiangsu.
• In light of our recent valuation report, it seems possible that Dioo Microcircuits Jiangsu is trading beyond its estimated value.

Landai Technology Group (SZSE:002765)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Landai Technology Group Corp., Ltd. specializes in the research, development, manufacture, and sale of power transmission assemblies, transmission parts, and die-casting products for the automotive, textile machinery, and general machinery industries in China with a market cap of CN¥6.39 billion.

Operations: Revenue segments for the company include power transmission assemblies, transmission parts, and die-casting products primarily serving the automotive, textile machinery, and general machinery sectors in China.

Insider Ownership: 31.3%

Landai Technology Group is poised for growth, with revenue expected to increase by 16.4% annually, outpacing the broader Chinese market's 13.3%. Earnings are projected to grow significantly at 91.63% per year, and the company is anticipated to become profitable within three years. Despite a low forecasted return on equity of 8.9%, insider ownership remains strong with no recent substantial insider trading activity reported. Recent dividend affirmations reflect confidence in future profitability.

• Click here to discover the nuances of Landai Technology Group with our detailed analytical future growth report.
• Our expertly prepared valuation report Landai Technology Group implies its share price may be too high.

AcrobiosystemsLtd (SZSE:301080)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Acrobiosystems Co., Ltd. develops and manufactures recombinant proteins, antibodies, and other biological reagents for pharmaceutical and biotechnology companies as well as scientific research institutions, with a market cap of CN¥5.86 billion.

Operations: The company's revenue primarily comes from Research and Experimental Development, totaling CN¥583.70 million.

Insider Ownership: 37.3%

Acrobiosystems Ltd. is positioned for growth, with earnings expected to rise significantly at 29.48% annually, surpassing the Chinese market's 25.1%. Despite a decline in profit margins from 31.1% to 18.3%, revenue growth is forecasted at 18.9%, outpacing the market's average of 13.3%. The company recently completed a share buyback worth CNY 6 million and affirmed its dividend plan, indicating confidence in its financial stability despite low return on equity forecasts (6.5%).

• Click to explore a detailed breakdown of our findings in AcrobiosystemsLtd's earnings growth report.
• Our valuation report here indicates AcrobiosystemsLtd may be overvalued.

Where To Now?

• Click through to start exploring the rest of the 1475 Fast Growing Companies With High Insider Ownership now.
• Shareholder in one or more of these companies? Ensure you're never caught off-guard by adding your portfolio in Simply Wall St for timely alerts on significant stock developments.
• Elevate your portfolio with Simply Wall St, the ultimate app for investors seeking global market coverage.

Interested In Other Possibilities?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.The analysis only considers stock directly held by insiders. It does not include indirectly owned stock through other vehicles such as corporate and/or trust entities. All forecast revenue and earnings growth rates quoted are in terms of annualised (per annum) growth rates over 1-3 years.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com